Zobrazeno 1 - 10
of 25
pro vyhledávání: '"E L, Trisvetova"'
Autor:
E. L. Trisvetova
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 20, Iss 2, Pp 249-257 (2024)
Non-syndromic mitral valve prolapse (MVP) is a common disease. In most cases, its benign course is noted, however, a connection between MVP and ventricular arrhythmias is reported, as well as sudden cardiac death. Clinical signs (chest pain, syncope/
Externí odkaz:
https://doaj.org/article/aeb347a470b6469fb9b41305b6153bb1
Autor:
E. L. Trisvetova
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 19, Iss 2, Pp 186-196 (2023)
In a significant number of patients with symptoms of angina pectoris or myocardial infarction with ischemic changes in the myocardium, according to the results of instrumental research methods, there is no hemodynamically significant stenosis of the
Externí odkaz:
https://doaj.org/article/501bf0b8bff44cffa9074f45ac141b04
Autor:
E. L. Trisvetova
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 18, Iss 2, Pp 200-208 (2022)
The pandemic of coronavirus infection, the complex and insufficiently studied mechanisms of which cause disorders in the functions of many organs and systems of the body, has led to the emergence of new problems that are far from being resolved. Rese
Externí odkaz:
https://doaj.org/article/546ca37e4dc64df2bdaa854bfb56687d
Autor:
E. L. Trisvetova
Publikováno v:
Научно-практическая ревматология, Vol 58, Iss 5, Pp 544-549 (2020)
The article presents information about a rare hereditary disease – primary hypertrophic osteoarthropathy with autosomal dominant and autosomal recessive inheritance. Genetic heterogeneity is responsible for the clinical polymorphism of symptoms tha
Externí odkaz:
https://doaj.org/article/098d358a896c4626b959eaeb814d3f78
Autor:
E. L. Trisvetova
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 15, Iss 3, Pp 431-438 (2019)
Fibromuscular dysplasia of the coronary arteries is a rare non-atherosclerotic and non-inflammatory vascular lesion that is asymptomatic until serious complications develop: stenosis, dissection, rupture, sudden cardiac death. Since there are no long
Externí odkaz:
https://doaj.org/article/bb8aa82e32e940ac8972df5c956d3133
Autor:
E. L. Trisvetova, S. V. Gubkin
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 12, Iss 1, Pp 79-86 (2016)
Indications and efficacy of drugs used for the treatment of pulmonary hypertension are considered. Stages of the treatment of pulmonary arterial hypertension are discussed, including maintenance therapy, specific therapy with calcium channel blockers
Externí odkaz:
https://doaj.org/article/edc9fa6cd8d24e51a0b71da2e21ab9a6
Autor:
E. L. Trisvetova
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 8, Iss 4, Pp 545-553 (2015)
Magnesium is a macronutrient that is needed for normal body functions. Magnesium deficiency resulting from the influence of exogenous and endogenous factors, is diagnosed by clinical manifestations, resembling the known disease. Magnesium deficiency
Externí odkaz:
https://doaj.org/article/c426fb961f6a43068515fc39844a157c
OPTIMIZING THE TREATMENT OF PATIENTS WITH HYPERTENSION AND CORONARY HEART DISEASE WITH LERCANIDIPINE
Autor:
E. L. Trisvetova
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 10, Iss 3, Pp 339-345 (2015)
Comorbidity of cardiovascular diseases reciprocally aggravates their course and induces the need to use safety and well-tolerated drugs. Pharmacological and pharmacokinetic properties of lercanidipine – the third-generation calcium channel blocker
Externí odkaz:
https://doaj.org/article/64cbd92b46de4273bab9f1cebc90fd81
Autor:
E. L. Trisvetova
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 2, Pp 89-93 (2013)
Diagnostic criteria are presented for the syndromes related to mutations of fibrillin gene type 1 (such as Marfan syndrome, ectopia lentis, MASS phenotype, mitral valve prolapse syndrome, stiff skin syndrome, Shprintzen-Goldberg syndrome) and for the
Externí odkaz:
https://doaj.org/article/3dd131e1410c42dab0cdac73c49c9d5d
Publikováno v:
Arkhiv patologii. 81:57
Heart involvement in sarcoidosis is diagnosed in vivo in 5-7%, at autopsy in 25% of cases as a manifestation of a systemic process and an isolated one. Difficulties in the diagnosis of isolated sarcoidosis are due to the absence of known causes of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6843cfe0762bdb4179333dd33a112837
https://doi.org/10.17116/patol20198101157
https://doi.org/10.17116/patol20198101157